Contrast agent gadobenate dimeglumine may be safe for patients with renal disease who require dialysis.
Case History: 7-year-old female with complaints of convulsions for one year.
A new, free, website provides comprehensive answers to complex questions about MRI.
Chinese researchers find more unruptured cerebral aneurysms using magnetic resonance angiography.
In the coming months, Lantheus Medical Imaging plans to introduce an MR blood pool contrast agent to the U.S. market under the brand name Ablavar. From its booth on the RSNA exhibit floor, company staff will be available to discuss key points about the agent, which was originally developed by Epix Pharmaceuticals and branded under the name Vasovist.
Innovation has always been the name of the game for the annual meeting of the International Society for Magnetic Resonance in Medicine. The 17th annual meeting beginning Saturday in Honolulu again showcases MRI science in action. But for this meeting, organizers added new features emphasizing MRI’s clinical applications and capitalizing on new communications technologies to encourage interactions between presenters and attendees at the show.
Studies examining the clinical histories
of patients who developed
nephrogenic systemic fibrosis after
treatment at distinguished teaching
hospitals in New York City and
Vienna suggest that gadoliniumbased
contrast dose and post-MRI
hemodialysis are keys to controlling
the rare but deadly skin disorder
After prolonged deliberation and repeated demands for more research, the FDA has approved Vasovist (gadofosveset trisodium), the first contrast imaging agent to gain regulatory clearance specifically for MR angiography.
Simple strategies, based on past experience with contrast-enhanced MRI for patients with compromised renal function, have helped radiologists and allied physicians bring the incidence of nephrogenic systemic fibrosis, a rare but deadly skin disorder, under control.
Noncontrast MR angiography provides an alternative to the more common contrast-enhanced MRA administered with a gadubutrol-based agent, according to a report presented at the RSNA meeting Tuesday morning.